文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

胃食管反流病:抑酸药物的最新进展

GERD: Latest update on acid-suppressant drugs.

作者信息

Al-Frejat Zyad, Martini Nafiza, Esper Alia, Al-Frejat Diana, Younes Samer, Hanna Majd

机构信息

Faculty of Medicine, Al Baath University, Homs, Syria.

Faculty of Medicine, Damascus University, Damascus, Syria.

出版信息

Curr Res Pharmacol Drug Discov. 2024 Aug 23;7:100198. doi: 10.1016/j.crphar.2024.100198. eCollection 2024.


DOI:10.1016/j.crphar.2024.100198
PMID:39282236
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11393603/
Abstract

GERD is a very familiar diagnosis among health care providers due to its massive spread, and its symptoms can affect the quality of life for a respectable slice of its patients. Therefore, what can only be described as a logical consequence, a pursuit of a treatment that can both relieve symptoms and have minimal side effects is still ongoing to cover the large demographic affected by GERD. In the following review, analysis will be made of GERD, including possible regulatory activity, of certain drugs to the already discussed pathways involved in GERD patients.

摘要

由于胃食管反流病(GERD)广泛传播,它在医疗保健提供者中是一种非常常见的诊断,其症状会影响相当一部分患者的生活质量。因此,一种只能被描述为合乎逻辑的结果是,仍在继续寻求一种既能缓解症状又副作用最小的治疗方法,以覆盖受GERD影响的大量人群。在以下综述中,将对GERD进行分析,包括某些药物对GERD患者已讨论过的相关途径可能产生的调节作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f48e/11393603/dbc249c9bfdd/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f48e/11393603/949db189aebb/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f48e/11393603/dbc249c9bfdd/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f48e/11393603/949db189aebb/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f48e/11393603/dbc249c9bfdd/gr2.jpg

相似文献

[1]
GERD: Latest update on acid-suppressant drugs.

Curr Res Pharmacol Drug Discov. 2024-8-23

[2]
Review article: treatment of mild and severe cases of GERD.

Aliment Pharmacol Ther. 2002-7

[3]
Gastroesophageal reflux disease: pathophysiology and pharmacology overview.

J Assoc Acad Minor Phys. 2000

[4]
Acid suppression therapy: where do we go from here?

Dig Dis. 2006

[5]
Current pharmacological management of gastroesophageal reflux disease.

Gastroenterol Res Pract. 2013-6-26

[6]
A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease.

Am J Gastroenterol. 2000-2

[7]
Treatment of gastroesophageal reflux disease.

Pharm World Sci. 2005-12

[8]
HISTORICAL PERSPECTIVE OF GASTROESOPHAGEAL REFLUX DISEASE CLINICAL TREATMENT.

Arq Gastroenterol. 2019-8-13

[9]
AGA Clinical Practice Update on the Diagnosis and Management of Extraesophageal Gastroesophageal Reflux Disease: Expert Review.

Clin Gastroenterol Hepatol. 2023-6

[10]
[PPI: new strategies for GERD].

Nihon Rinsho. 2004-8

引用本文的文献

[1]
Octreotide combined with pantoprazole in the treatment of elderly patients with peptic ulcer complicated by upper gastrointestinal bleeding.

Front Pharmacol. 2025-6-18

[2]
Advances in Gastroesophageal Reflux Disease Management: Exploring the Role of Potassium-Competitive Acid Blockers and Novel Therapies.

Pharmaceuticals (Basel). 2025-5-9

本文引用的文献

[1]
Current Status of Anti-Reflux Surgery as a Treatment for GERD.

Medicina (Kaunas). 2024-3-21

[2]
Prokinetics-safety and efficacy: The European Society of Neurogastroenterology and Motility/The American Neurogastroenterology and Motility Society expert review.

Neurogastroenterol Motil. 2024-5

[3]
Updates in the Management of Erosive Esophagitis.

J Fam Pract. 2023-10

[4]
Expert Recommendations on Optimizing the Diagnosis and Management of Gastroesophageal Reflux Disease Associated with Comorbidities in the Indian Population.

J Assoc Physicians India. 2023-8

[5]
Vonoprazan: A New Potassium-Competitive Acid Blocker.

J Pharm Technol. 2023-6

[6]
AGA Clinical Practice Update on the Diagnosis and Management of Extraesophageal Gastroesophageal Reflux Disease: Expert Review.

Clin Gastroenterol Hepatol. 2023-6

[7]
Efficacy and Safety of Domperidone in Combination with Proton Pump Inhibitors in Gastroesophageal Reflux Disease: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.

J Clin Med. 2022-9-7

[8]
Vonoprazan Triple and Dual Therapy for Helicobacter pylori Infection in the United States and Europe: Randomized Clinical Trial.

Gastroenterology. 2022-9

[9]
Clinical trial: seven-day vonoprazan- versus 14-day proton pump inhibitor-based triple therapy for first-line Helicobacter pylori eradication.

Aliment Pharmacol Ther. 2022-8

[10]
Systematic review: Clinical effectiveness of interventions for the treatment of nocturnal gastroesophageal reflux.

Neurogastroenterol Motil. 2022-12

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索